Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from the Netherlands cohort study

被引:0
|
作者
Kjeld P van Houwelingen
Boukje AC van Dijk
Christina A Hulsbergen-van de Kaa
Leo J Schouten
Hanneke JM Gorissen
Jack A Schalken
Piet A van den Brandt
Egbert Oosterwijk
机构
[1] University Medical Center Nijmegen,Department of Urology
[2] Maastricht University,Department of Epidemiology, NUTRIM
[3] University Medical Center Nijmegen,Department of Pathology
来源
BMC Cancer | / 5卷
关键词
Renal Cell Cancer; Papillary Renal Cell Cancer; Chromophobe Renal Cell Cancer; Viable Tumor Tissue; Netherlands Cancer Registry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Targeting von Hippel-Lindau pathway in renal cell carcinoma
    Patel, Premal H.
    Chadalavada, Rajendrakumar S. V.
    Chaganti, R. S. K.
    Motzer, Robert J.
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7215 - 7220
  • [22] Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease
    Jonasch, Eric
    Donskov, Frede
    Iliopoulos, Othon
    Rathmell, W. Kimryn
    Narayan, Vivek K.
    Maughan, Benjamin L.
    Oudard, Stephane
    Else, Tobias
    Maranchie, Jodi K.
    Welsh, Sarah J.
    Thamake, Sanjay
    Park, Eric K.
    Perini, Rodolfo F.
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (22): : 2036 - 2046
  • [23] Precision surgery for Von Hippel-Lindau renal cell carcinoma
    Larcher, A.
    Belladelli, F.
    Fallara, G.
    Rowe, I.
    Ieva, A.
    Santangelo, M.
    Luciano, R.
    Doglioni, C.
    Mattioli, C.
    Sciarrone Alibrandi, M. T.
    Guazzarotti, G.
    Damascelli, A.
    Bellin, A.
    Canibus, D.
    Capitanio, U.
    Montorsi, F.
    De Cobelli, F.
    Bertini, R.
    Salonia, A.
    EUROPEAN UROLOGY, 2022, 81
  • [24] Management of renal cell carcinoma in von Hippel-Lindau disease
    Hes, FJ
    Slootweg, PJ
    van Vroonhoven, TJMV
    Hené, RJ
    Feldberg, MAM
    Zewald, RA
    van Amstel, JKP
    Höppener, JWM
    Pearson, PL
    Lips, CJM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (01) : 68 - 75
  • [25] RENAL-CELL CARCINOMA IN VON HIPPEL-LINDAU SYNDROME
    MALEK, RS
    OMESS, PJ
    BENSON, RC
    ZINCKE, H
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (02): : 236 - 238
  • [26] Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
    Ashouri, Kenan
    Mohseni, Sophia
    Tourtelot, John
    Sharma, Pranav
    Spiess, Philippe E.
    JOURNAL OF KIDNEY CANCER AND VHL, 2015, 2 (04): : 163 - 173
  • [27] Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort
    Zhang, Zedan
    Wang, Yi
    Yang, Wuping
    Liu, Tao
    Wang, Chuandong
    Huang, Cong
    Xu, Yawei
    Chen, Xiaolin
    Zhou, Jingcheng
    Wang, Yizhou
    Zhou, Xiaohua
    Gong, Yanqing
    Gong, Kan
    ISCIENCE, 2024, 27 (07)
  • [28] Cathepsin B overexpression correlate with von Hippel-Lindau tumor suppressor gene mutation in sporadic renal cell carcinoma
    Na, X
    Wu, G
    Ryan, CK
    Schoen, SR
    Di'santagnese, PA
    Messing, EM
    JOURNAL OF UROLOGY, 2003, 169 (04): : 143 - 144
  • [29] Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease
    Chambers, TP
    Fishman, EK
    Hruban, RH
    CLINICAL IMAGING, 1997, 21 (01) : 40 - 42
  • [30] Mutations of the VHL (von Hippel-Lindau) tumor suppressor gene in trichloroethene exposed patients with renal cell carcinoma
    Bruning, T
    Hornauer, M
    Weirich, G
    Thier, R
    Bolt, HM
    Brauch, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 617 - 617